Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wilden, now a core part of Gerresheimer Medical Systems, is a leading global specialist in the development and contract manufacturing of complex plastic systems for the pharmaceutical and healthcare industries. The company focuses on high-precision drug delivery devices, including inhalers, insulin pens, and auto-injectors, as well as various diagnostic and surgical disposables. Wilden provides a full-service value chain ranging from initial product design and mold making to automated cleanroom production and final assembly. Following its acquisition by Gerresheimer in 2007, the group expanded its reach as a premier CDMO for large-scale medical device production. Its expertise is particularly noted in the management of multi-component injection molding and complex mechanical assembly for life science applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wilden.